Drug Approval | February 25, 2023
Pfizer’s Elranatamab receives FDA and EMA filing acceptance
Submissions based on favorable MagnetisMM-3 trial results in patients with relapsed or refractory multiple myeloma
Submissions based on favorable MagnetisMM-3 trial results in patients with relapsed or refractory multiple myeloma
More than 5 lakh patients availed the benefit of queue-less OPD registration using this service
N-nitroso dimethylamine (NDMA) is a probable human carcinogen and tts effects on humans rely on observational studies.
Designation based on positive data from Phase 2b KEYNOTE-942/mRNA-4157-P201 trial
In a bid to better leverage its clinical expertise and drive quality reporting across its centres, Thyrocare has added SigTuple’s AI100 to automate the microscopic review in its laboratories
Becomes the 1st diagnostics company in India to launch BD MAX MDR TB test
There is a fast resurgence in the transplant activities post COVID
IAGES to focus on upskilling and adoption of advanced Minimal Access Surgery technologies in 2023
The company has launched its new range of 25 allopathy ophthalmic products including GUERIMOD, GUERIPRED, BIMATO MST etc. for curing various diseases related to eyes
Investment proposals to the tune of Rs. 54,000 crore has been received in the healthcare and Rs. 17,000 crore has been received in medical education sector
Subscribe To Our Newsletter & Stay Updated
